亿帆医药 (002019.SZ)
10.71 -0.24(-2.190%)
+ 收藏
今开:10.93 最高:10.97 成交量:10.87万手
昨收:10.95 最低:10.66 成交额:1.17亿
利润表(亿帆医药)
上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
一、营业总收入(元) | 3,858,211,534.78 | 2,632,089,783.35 | 1,325,969,392.93 | 4,068,107,333.94 | 2,930,281,528.53 | 1,944,049,304.17 | 938,532,039.13 |
营业收入(元) | 3,858,211,534.78 | 2,632,089,783.35 | 1,325,969,392.93 | 4,068,107,333.94 | 2,930,281,528.53 | 1,944,049,304.17 | 938,532,039.13 |
二、营业总成本(元) | 3,531,892,029.96 | 2,363,162,281.95 | 1,189,455,724.43 | 4,041,933,714.51 | 2,757,500,720.62 | 1,797,130,144.57 | 892,797,132.61 |
营业成本(元) | 2,019,896,584.59 | 1,374,809,781.73 | 697,906,895.23 | 2,121,932,748.61 | 1,447,589,399.30 | 963,097,074.16 | 480,751,477.19 |
研发费用(元) | 182,438,180.13 | 114,594,982.81 | 59,876,908.40 | 312,383,570.82 | 175,652,095.07 | 109,536,560.73 | 47,510,975.21 |
营业税金及附加(元) | 37,868,104.71 | 29,528,550.80 | 10,025,427.34 | 45,949,999.29 | 33,723,919.89 | 22,340,546.17 | 10,831,847.60 |
销售费用(元) | 962,031,504.27 | 638,226,395.90 | 314,782,530.39 | 1,119,147,520.07 | 780,288,516.31 | 507,666,568.21 | 249,727,490.53 |
管理费用(元) | 279,807,921.91 | 173,744,849.65 | 89,535,119.03 | 383,691,613.80 | 278,049,633.51 | 176,825,050.20 | 86,182,842.98 |
财务费用(元) | 49,849,734.35 | 32,257,721.06 | 17,328,844.04 | 58,828,261.92 | 42,197,156.54 | 17,664,345.10 | 17,792,499.10 |
其中:利息费用(元) | 52,655,529.37 | 33,443,730.44 | 16,667,241.75 | 75,552,151.11 | 58,047,661.87 | 40,817,823.83 | 20,555,558.87 |
其中:利息收入(元) | 7,047,405.26 | 4,334,459.37 | 2,317,719.10 | 13,129,460.86 | 10,786,554.84 | 9,435,395.80 | 5,437,967.82 |
三、其他经营收益 | |||||||
加:公允价值变动收益(元) | - | - | - | 10,256.50 | - | - | - |
加:投资收益(元) | -6,930,848.09 | -1,288,863.23 | -4,560,572.47 | -15,069,239.18 | -12,421,912.45 | -7,483,572.47 | -4,767,874.19 |
其中:对联营企业和合营企业的投资收益(元) | -21,704,089.60 | -15,244,148.07 | -4,521,042.90 | -19,233,437.83 | -13,668,494.35 | -7,932,311.95 | -4,545,912.07 |
资产处置收益(元) | 34,217,935.54 | 2,198,867.23 | 2,282,436.45 | 2,570,803.44 | 2,410,590.40 | 902,637.40 | -136,096.63 |
资产减值损失(元) | -20,693,476.75 | -10,823,614.64 | -4,285,452.76 | -887,364,040.01 | -23,395,892.98 | -15,597,687.71 | -1,221,138.65 |
信用减值损失(元) | -50,850,079.08 | -50,826,479.16 | -16,262,223.14 | -64,424,928.05 | -43,820,014.14 | -37,265,634.16 | -124,882.34 |
其他收益(元) | 101,570,508.05 | 83,284,962.09 | 45,164,802.43 | 55,391,348.60 | 29,569,692.80 | 15,108,665.85 | 4,844,318.49 |
四、营业利润(元) | 383,633,544.49 | 291,472,373.69 | 158,852,659.01 | -882,712,179.27 | 125,123,271.54 | 102,583,568.51 | 44,329,233.20 |
加:营业外收入(元) | 3,460,039.53 | 2,854,677.57 | 184,120.98 | 18,550,050.50 | 11,226,214.75 | 2,033,369.86 | 1,072,516.13 |
减:营业外支出(元) | 2,036,783.86 | 676,406.70 | 122,948.13 | 4,868,578.14 | 1,578,814.31 | 915,263.08 | 160,695.29 |
五、利润总额(元) | 385,056,800.16 | 293,650,644.56 | 158,913,831.86 | -869,030,706.91 | 134,770,671.98 | 103,701,675.29 | 45,241,054.04 |
减:所得税费用(元) | 77,296,802.65 | 81,204,665.33 | 41,365,369.65 | 16,618,640.14 | 33,666,158.17 | 19,029,199.46 | 1,250,866.94 |
六、净利润(元) | 307,759,997.51 | 212,445,979.23 | 117,548,462.21 | -885,649,347.05 | 101,104,513.81 | 84,672,475.83 | 43,990,187.10 |
(一)按经营持续性分类 | |||||||
持续经营净利润(元) | 307,759,997.51 | 212,445,979.23 | 117,548,462.21 | -885,649,347.05 | 101,104,513.81 | 84,672,475.83 | 43,990,187.10 |
(二)按所有权归属分类 | |||||||
归属于母公司股东的净利润(元) | 366,380,130.89 | 253,226,615.60 | 146,099,164.96 | -551,073,063.61 | 146,845,650.22 | 108,660,386.75 | 64,774,428.20 |
少数股东损益(元) | -58,620,133.38 | -40,780,636.37 | -28,550,702.75 | -334,576,283.44 | -45,741,136.41 | -23,987,910.92 | -20,784,241.10 |
扣除非经常性损益后的净利润(元) | 251,980,774.08 | 179,419,522.02 | 110,319,647.02 | -532,628,603.81 | 113,350,879.98 | 94,194,407.44 | 59,978,038.28 |
七、每股收益 | |||||||
一、基本每股收益(元) | 0.30 | 0.21 | 0.12 | -0.45 | 0.12 | 0.09 | 0.05 |
二、稀释每股收益(元) | 0.30 | 0.21 | 0.12 | -0.45 | 0.12 | 0.09 | 0.05 |
八、其他综合收益(元) | -10,825,241.37 | -17,359,424.85 | -13,919,671.49 | 51,238,166.35 | 25,497,648.65 | 60,181,819.72 | -17,632,901.83 |
归属于母公司股东的其他综合收益(元) | -10,798,610.70 | -17,384,862.25 | -13,912,833.38 | 50,967,750.41 | 25,076,787.09 | 60,132,211.21 | -17,108,117.30 |
归属于少数股东的其他综合收益(元) | -26,630.67 | 25,437.40 | -6,838.11 | 270,415.94 | 420,861.56 | 49,608.51 | -524,784.53 |
九、综合收益总额(元) | 296,934,756.14 | 195,086,554.38 | 103,628,790.72 | -834,411,180.70 | 126,602,162.46 | 144,854,295.55 | 26,357,285.27 |
归属于母公司所有者的综合收益总额(元) | 355,581,520.19 | 235,841,753.35 | 132,186,331.58 | -500,105,313.20 | 171,922,437.31 | 168,792,597.96 | 47,666,310.90 |
归属于少数股东的综合收益总额(元) | -58,646,764.05 | -40,755,198.97 | -28,557,540.86 | -334,305,867.50 | -45,320,274.85 | -23,938,302.41 | -21,309,025.63 |
公告日期 | 2024-10-31 | 2024-08-15 | 2024-04-24 | 2024-04-20 | 2023-10-31 | 2023-08-30 | 2023-04-29 |
审计意见(境内) | 标准无保留意见 | ||||||
原始财报文件下载 | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) |
上市前/上市后 |
报表类型 |
一、营业总收入(元) |
营业收入(元) |
二、营业总成本(元) |
营业成本(元) |
研发费用(元) |
营业税金及附加(元) |
销售费用(元) |
管理费用(元) |
财务费用(元) |
其中:利息费用(元) |
其中:利息收入(元) |
三、其他经营收益 |
加:公允价值变动收益(元) |
加:投资收益(元) |
其中:对联营企业和合营企业的投资收益(元) |
资产处置收益(元) |
资产减值损失(元) |
信用减值损失(元) |
其他收益(元) |
四、营业利润(元) |
加:营业外收入(元) |
减:营业外支出(元) |
五、利润总额(元) |
减:所得税费用(元) |
六、净利润(元) |
(一)按经营持续性分类 |
持续经营净利润(元) |
(二)按所有权归属分类 |
归属于母公司股东的净利润(元) |
少数股东损益(元) |
扣除非经常性损益后的净利润(元) |
七、每股收益 |
一、基本每股收益(元) |
二、稀释每股收益(元) |
八、其他综合收益(元) |
归属于母公司股东的其他综合收益(元) |
归属于少数股东的其他综合收益(元) |
九、综合收益总额(元) |
归属于母公司所有者的综合收益总额(元) |
归属于少数股东的综合收益总额(元) |
公告日期 |
审计意见(境内) |
原始财报文件下载 |
Showing 1 to 45 of 45 entries